SCHEMBL30906559

CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.57

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	7/20	0.49

▸	CALCRL	Q16602	5/20	0.48

▸	CRHR1	P34998	1/20	0.47

▸	CRHR2	Q13324	1/20	0.47

▸	RAMP1	O60894	1/20	0.45

▸	NPY2R	P49146	5/20	0.45

▸	NPY4R	P50391	5/20	0.45

▸	NPY5R	Q15761	5/20	0.45

▸	RAMP3	O60896	4/20	0.45

▸	NPY1R	P25929	3/20	0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906329	1.00	CALCR (0.49)	CALCRCALCRLCRHR1CRHR2RAMP1
SCHEMBL30906433	0.99	CALCRL (0.48)	CALCRCALCRLCRHR1CRHR2RAMP1
SCHEMBL30906436	0.98	CALCR (0.49)	CALCRCALCRLCRHR1CRHR2NPY2R
SCHEMBL30906410	0.97	CALCRL (0.48)	CALCRCALCRLCRHR1CRHR2NPY2R
SCHEMBL30906398	0.95	CALCR (0.49)	CALCRCALCRLNPY2RNPY4RNPY5R
SCHEMBL30906384	0.95	CALCR (0.49)	CALCRCALCRLNPY2RNPY4RNPY5R
SCHEMBL30906457	0.94	CALCR (0.49)	CALCRCALCRLCRHR1CRHR2RAMP1
SCHEMBL30906467	0.94	CALCR (0.50)	CALCRCALCRLNPY2RNPY4RNPY5R
SCHEMBL30906512	0.91	CALCR (0.53)	CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL30906514	0.91	CALCR (0.49)	CALCRCALCRLNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed